Free Trial

Alpine Immune Sciences (ALPN) Stock Forecast & Price Target

Notice: This company has been marked as potentially delisted and may not be actively trading.

Alpine Immune Sciences - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 11 Wall Street analysts who have issued ratings for Alpine Immune Sciences in the last 12 months, the stock has a consensus rating of "Hold." Out of the 11 analysts, 8 have given a hold rating, and 3 have given a buy rating for ALPN.

Consensus Price Target

$52.33
-19.45% Downside
High Forecast$65.00
Average Forecast$52.33
Low Forecast$18.00

According to the 11 analysts' twelve-month price targets for Alpine Immune Sciences, the average price target is $52.33. The highest price target for ALPN is $65.00, while the lowest price target for ALPN is $18.00. The average price target represents a forecasted downside of -19.45% from the current price of $64.97.

TypeCurrent Forecast
7/22/23 to 7/21/24
1 Month Ago
6/22/23 to 6/21/24
3 Months Ago
4/23/23 to 4/22/24
1 Year Ago
7/22/22 to 7/22/23
Consensus Rating
Hold
Hold
Hold
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
4 Buy rating(s)
Hold
8 Hold rating(s)
8 Hold rating(s)
8 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$52.33$52.33$50.33$16.40
Forecasted Upside-19.45% Downside23.21% Upside28.70% Upside132.38% Upside
Get Alpine Immune Sciences Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ALPN and its competitors with MarketBeat's FREE daily newsletter.

ALPN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ALPN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Alpine Immune Sciences Stock vs. The Competition

TypeAlpine Immune SciencesMedical CompaniesS&P 500
Consensus Rating Score
2.27
2.72
2.51
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside-19.45% Downside3,282.89% Upside10.04% Upside
News Sentiment RatingNeutral News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/16/2024Wedbush
3 of 5 stars
R. Driscoll
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$65.00+0.05%
4/16/2024TD Cowen
4 of 5 stars
 Reiterated RatingBuy ➝ Hold
4/12/2024SVB Leerink
1 of 5 stars
 DowngradeOutperform ➝ Market Perform$42.00 ➝ $65.00+0.87%
4/11/2024Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
T. Smith
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform
4/11/2024HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Pantginis
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral
4/11/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight ➝ Equal Weight$47.00 ➝ $65.00+38.18%
4/11/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Sector Perform$41.00 ➝ $65.00+38.18%
4/11/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Peer Perform
4/9/2024Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$55.00+42.75%
3/19/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$33.00 ➝ $44.00+24.05%
10/17/2023Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$18.00+80.00%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 06:13 AM ET.

ALPN Forecast - Frequently Asked Questions

What is Alpine Immune Sciences' forecast for 2024?

According to the research reports of 11 Wall Street equities research analysts, the average twelve-month stock price forecast for Alpine Immune Sciences is $52.33, with a high forecast of $65.00 and a low forecast of $18.00.

Should I buy or sell Alpine Immune Sciences stock right now?

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Alpine Immune Sciences in the last year. There are currently 8 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" ALPN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ALPN, but not buy additional shares or sell existing shares.

Does Alpine Immune Sciences's stock price have much upside?

According to analysts, Alpine Immune Sciences's stock has a predicted upside of 23.21% based on their 12-month stock forecasts.

What analysts cover Alpine Immune Sciences?

Alpine Immune Sciences has been rated by research analysts at Wedbush in the past 90 days.

Do Wall Street analysts like Alpine Immune Sciences more than its competitors?

Analysts like Alpine Immune Sciences less than other "medical" companies. The consensus rating for Alpine Immune Sciences is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how ALPN compares to other companies.


This page (NASDAQ:ALPN) was last updated on 7/21/2024 by MarketBeat.com Staff

From Our Partners